OpenAlex
PricingAboutJobs
Log inGet started
Work

Trimethylamine N-oxide (TMAO) as a New Potential Therapeutic Target for Insulin Resistance and Cancer

HTML

Year: 2017
Type: article
Source: Current Pharmaceutical Design
DOI: 10.2174/1381612823666170622095324
Authors: Jens Oellgaard, Signe Abitz Winther, Tobias Schmidt Hansen, Peter Rossing, Bernt Johan von Scholten
Institutions: Steno Diabetes Center Copenhagen, Zealand University Hospital
Language: English

Topic: Gut microbiota and health
Subfield: Molecular Biology
Field: Biochemistry, Genetics and Molecular Biology
Domain: Life Sciences
Keywords: trimethylamine N-oxide, insulin resistance, gastrointestinal cancer, gut microbiota, trimethylamine, choline, L-carnitine, animal products, dietary intervention, N-nitroso compounds, DNA damage, epigenetic modifications, meldonium, 3,3-dimethyl-1-butanol, therapeutic target, atherosclerotic cardiovascular disease
SDG: Good health and well-being

Open Access status: closed

Funder: Steno Diabetes Center Copenhagen
Award: G6433152044
OpenAlex ID: W2648593275
FWCI: 3.371
Cites:
Cited by: 143
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms
Security